With three FDA-approved products, the mission of ADMA Biologics is to continue to successfully commercialize plasma-derived, human immune globulins targeted to specific patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.
Our dedicated patient support hub helps simplify access to ASCENIV™ and BIVIGAM®
Can help eligible patients:
Maximize insurance benefits and minimize overall treatment costs
Locate alternative funding and other payment options, such as nonprofit patient assistance foundations
Supports providers and staff with:
Benefits verification to determine coverage, including out-of-pocket costs, and payer requirements
Claims, reimbursement support, and appeals
ADMA is committed to helping patients with access to their therapy. If you need additional information on financial assistance or resources, the National Organization for Rare Disorders (NORD) may be able to assist.
Contact the NORD Helpline at 1-800-999-6673 or visit rarediseases.org/contact. Helpline hours: Monday–Thursday 8:30am–7:00pm ET; Friday 8:30am–6:00pm ET
Healthcare professionals, this guide can help you get started
The link you have selected will take you outside of the ADMA Biologics corporate website. The site you will be entering is intended for US audiences only. Do you wish to continue?
This information is aimed exclusively at authorized US healthcare providers to prescribe or supply medicinal products and its correct interpretation requires specialized training.
![Logo for BIVIGAM [Immune Globulin Intravenous (Human), 10% Liquid]](https://www.admabiologics.com/hubfs/bivigam-2.svg)
